...
search icon
pstv-img

Plus Therapeutics Inc Share Price

PSTV
NAQ
$0.28
+$0
(0%)
1D
Industry: Biotechnology Sector: Health Care

Plus Therapeutics Inc Analyst Forecast

Plus Therapeutics Inc Share Price Chart

Plus Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$50.48M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.80M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.85
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.16 L
$2.31 H
$0.28

About Plus Therapeutics Inc, Common Stock

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is REYOBIQ, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests, such as the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas. more

Industry: BiotechnologySector: Health Care

Plus Therapeutics Inc Stock Returns

Time FramePSTVSectorS&P500
1-Week Return4.81%0.91%-0.82%
1-Month Return-2.41%1.46%1.28%
3-Month Return-44.51%3.33%3.98%
6-Month Return-47.59%16.03%6.73%
1-Year Return-76.02%9.1%12.24%
3-Year Return-94.9%21.02%72.07%
5-Year Return-99.44%36.15%75.69%
10-Year Return-100%138.89%258.38%

Plus Therapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue303.00K-224.00K4.91M5.82M[{"date":"2020-12-31","value":5.2,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":3.85,"profit":true},{"date":"2023-12-31","value":84.36,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue2.70M66.00K712.00K9.69M852.00K[{"date":"2020-12-31","value":27.86,"profit":true},{"date":"2021-12-31","value":0.68,"profit":true},{"date":"2022-12-31","value":7.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":8.79,"profit":true}]
Gross Profit(2.40M)(66.00K)(488.00K)(4.78M)4.97M[{"date":"2020-12-31","value":-48.21,"profit":false},{"date":"2021-12-31","value":-1.33,"profit":false},{"date":"2022-12-31","value":-9.81,"profit":false},{"date":"2023-12-31","value":-96.08,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin(791.09%)-(217.86%)(97.23%)85.37%[{"date":"2020-12-31","value":-926.65,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-255.19,"profit":false},{"date":"2023-12-31","value":-113.89,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses7.19M12.43M19.22M8.54M19.67M[{"date":"2020-12-31","value":36.54,"profit":true},{"date":"2021-12-31","value":63.18,"profit":true},{"date":"2022-12-31","value":97.75,"profit":true},{"date":"2023-12-31","value":43.44,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(9.58M)(12.49M)(19.71M)(13.32M)(14.70M)[{"date":"2020-12-31","value":-958400000,"profit":false},{"date":"2021-12-31","value":-1249200000,"profit":false},{"date":"2022-12-31","value":-1971200000,"profit":false},{"date":"2023-12-31","value":-1332100000,"profit":false},{"date":"2024-12-31","value":-1469500000,"profit":false}]
Total Non-Operating Income/Expense286.00K(1.82M)(1.13M)10.00K(1.73M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-636.36,"profit":false},{"date":"2022-12-31","value":-394.06,"profit":false},{"date":"2023-12-31","value":3.5,"profit":true},{"date":"2024-12-31","value":-606.29,"profit":false}]
Pre-Tax Income(8.24M)(13.40M)(20.27M)(13.32M)(12.98M)[{"date":"2020-12-31","value":-824100000,"profit":false},{"date":"2021-12-31","value":-1339900000,"profit":false},{"date":"2022-12-31","value":-2027500000,"profit":false},{"date":"2023-12-31","value":-1331600000,"profit":false},{"date":"2024-12-31","value":-1297800000,"profit":false}]
Income Taxes1.11M932.00K563.00K--[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":84.19,"profit":true},{"date":"2022-12-31","value":50.86,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(9.35M)(14.33M)(20.84M)--[{"date":"2020-12-31","value":-934800000,"profit":false},{"date":"2021-12-31","value":-1433100000,"profit":false},{"date":"2022-12-31","value":-2083800000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(8.24M)(13.40M)(20.27M)(13.32M)(12.98M)[{"date":"2020-12-31","value":-824100000,"profit":false},{"date":"2021-12-31","value":-1339900000,"profit":false},{"date":"2022-12-31","value":-2027500000,"profit":false},{"date":"2023-12-31","value":-1331600000,"profit":false},{"date":"2024-12-31","value":-1297800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(8.24M)(13.40M)(20.27M)(13.32M)(12.98M)[{"date":"2020-12-31","value":-824100000,"profit":false},{"date":"2021-12-31","value":-1339900000,"profit":false},{"date":"2022-12-31","value":-2027500000,"profit":false},{"date":"2023-12-31","value":-1331600000,"profit":false},{"date":"2024-12-31","value":-1297800000,"profit":false}]
EPS (Diluted)(1.60)(1.13)(0.84)(2.57)(2.17)[{"date":"2020-12-31","value":-160,"profit":false},{"date":"2021-12-31","value":-113,"profit":false},{"date":"2022-12-31","value":-84,"profit":false},{"date":"2023-12-31","value":-257,"profit":false},{"date":"2024-12-31","value":-217,"profit":false}]

Plus Therapeutics Inc Ratios

Plus Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

PSTV
Cash Ratio 0.98
Current Ratio 1.29

Plus Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PSTV
ROA (LTM) -65.58%
ROE (LTM) -522.50%

Plus Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PSTV
Debt Ratio Lower is generally better. Negative is bad. 0.73
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.27

Plus Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PSTV
Trailing PE NM
Forward PE NM
P/S (TTM) 9.51
P/B 9.75
Price/FCF NM
EV/R 18.19
EV/Ebitda NM

FAQs

What is Plus Therapeutics Inc share price today?

Plus Therapeutics Inc (PSTV) share price today is $0.28

Can Indians buy Plus Therapeutics Inc shares?

Yes, Indians can buy shares of Plus Therapeutics Inc (PSTV) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PSTV stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Plus Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Plus Therapeutics Inc (PSTV) via the Vested app. You can start investing in Plus Therapeutics Inc (PSTV) with a minimum investment of $1.

How to invest in Plus Therapeutics Inc shares from India?

You can invest in shares of Plus Therapeutics Inc (PSTV) via Vested in three simple steps:

  • Click on Sign Up or Invest in PSTV stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Plus Therapeutics Inc shares
What is Plus Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Plus Therapeutics Inc (PSTV) is $2.31. The 52-week low price of Plus Therapeutics Inc (PSTV) is $0.16.

What is Plus Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Plus Therapeutics Inc (PSTV) is

What is Plus Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Plus Therapeutics Inc (PSTV) is 9.75

What is Plus Therapeutics Inc dividend yield?

The dividend yield of Plus Therapeutics Inc (PSTV) is 0.00%

What is the Market Cap of Plus Therapeutics Inc?

The market capitalization of Plus Therapeutics Inc (PSTV) is $50.48M

What is Plus Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Plus Therapeutics Inc is PSTV

How Can Investors Use Plus Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Plus Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Plus Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Plus Therapeutics Inc shares for Indian investors?

When investing in Plus Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Plus Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Plus Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Plus Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Plus Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top